Microsoft Anthropic in Talks Over Custom AI Chip Deal Following 5 Billion Investment Oleksandr Usyk vs Rico Verhoeven DAZN Event Financial and Business Implications of the Pyramid Fight Summer Electric Bills Surge as Record Heat and Higher Rates Drive Up Cooling Costs Prewar Gas Prices Unlikely to Return in 2026 Even with Iran Peace Deal Experts Suggest Ferrari Luce EV Launch Triggers 6 Share Drop in Milan Trading Okta Shares Climb on Earnings Beat and AIAgent Identity Market Potential BCC Q1 2026 Earnings Earnings Beat Expectations Amid Challenging Market Conditions RMTI Q1 2026 Earnings EPS Misses Estimates Stock Declines on Weak Performance VOYA Q1 2026 Earnings EPS Surpasses Estimates by 8 Amid Solid Underwriting and Fee Income Annovis Bio Q1 2026 Earnings EPS Misses Estimates as PreClinical Spending Intensifies RTX Q1 2026 Earnings EPS Surges Past Estimates with 161 Surprise Euroseas Ltd ESEA Q1 2026 Earnings EPS Surges Past Estimates on Strong Charter Rates Honda Motor HMC Edges Higher Amid Modest Gains Key Levels in Focus Sohucom SOHU Hovers Near Resistance as Volume Remains Subdued JLong Group Limited JL Sees Modest Gains Tests Key Resistance Zone DMII Holds Steady at 1007 Amid Quiet Trading Key Support and Resistance Levels in Focus Genprex Inc GNPX Edges Higher Amid Biotech Sector Cautious Tone Portfolio Manager Trims HighFlying Stock After Parabolic Rally PRDO Q1 2026 Earnings Profit Beats Expectations as Company Delivers Strong EPS Surprise AbCellera Biologics ABCL Surges 53 as Biotech Sentiment Improves WST Q1 2026 Earnings EPS Surges 2578 Past Estimates Driving Positive Market Reaction STEL Q1 2026 Earnings Strong EPS Beat Amid Marginal Stock Decline 374Water Inc SCWO Q1 2026 Earnings Narrowing Losses and Commercial Progress Highlight a Quarter of Transition SSB Q1 2026 Earnings EPS Beats Estimates Amid Stable Banking Operations ATOS Q1 2026 Earnings EPS Surprise of 8223 Highlights Cost Management in ClinicalStage Biotech ALGT Q1 2026 Earnings EPS Surpasses Estimates by 1214 PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances